These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 12184055

  • 21. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA, Onuigbo NT.
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [Abstract] [Full Text] [Related]

  • 22. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 23. [Are all antihypertensive drugs renoprotective?].
    Wolf S, Risler T.
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [Abstract] [Full Text] [Related]

  • 24. Research into the glomerular podocyte--is it relevant to diabetic nephropathy?
    White KE.
    Diabet Med; 2006 Jul; 23(7):715-9. PubMed ID: 16842474
    [Abstract] [Full Text] [Related]

  • 25. Requirement of drug development for chronic renal disease: Other strategies than blockade of the renin-angiotensin system.
    Okamoto T.
    Int J Mol Med; 2003 May; 11(5):651-4. PubMed ID: 12684706
    [Abstract] [Full Text] [Related]

  • 26. Targeted deletion of angiotensin II type 1A receptor does not protect mice from progressive nephropathy of overload proteinuria.
    Benigni A, Corna D, Zoja C, Longaretti L, Gagliardini E, Perico N, Coffman TM, Remuzzi G.
    J Am Soc Nephrol; 2004 Oct; 15(10):2666-74. PubMed ID: 15466271
    [Abstract] [Full Text] [Related]

  • 27. Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies.
    Ruggenenti P.
    Semin Nephrol; 2004 Mar; 24(2):158-67. PubMed ID: 15017528
    [Abstract] [Full Text] [Related]

  • 28. Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes.
    Sochett EB, Cherney DZ, Curtis JR, Dekker MG, Scholey JW, Miller JA.
    J Am Soc Nephrol; 2006 Jun; 17(6):1703-9. PubMed ID: 16672313
    [Abstract] [Full Text] [Related]

  • 29. Preventing end-stage renal disease in diabetic patients - dual blockade of the renin-angiotensin system (Part II).
    Jacobsen PK.
    J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):55-68. PubMed ID: 16470484
    [Abstract] [Full Text] [Related]

  • 30. The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study.
    Renke M, Tylicki L, Rutkowski P, Larczyński W, Aleksandrowicz E, Lysiak-Szydłowska W, Rutkowski B.
    Kidney Blood Press Res; 2008 Sep; 31(6):404-10. PubMed ID: 19092257
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [The nephropathies of reflux].
    Prog Urol; 1998 Nov; 8(5):703-25. PubMed ID: 9931953
    [No Abstract] [Full Text] [Related]

  • 40. Progression, Remission and Regression of Chronic Renal Diseases.
    Cortinovis M, Ruggenenti P, Remuzzi G.
    Nephron; 2016 Nov; 134(1):20-4. PubMed ID: 27096936
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.